Please do not leave this page until complete. This can take a few moments.
Alexion Pharmaceuticals Inc. has sold intellectual property related to a rare gene deficiency to a Boston biotech co-founded by two professors at the Yale School of Medicine.
Under the agreement, Inozyme Pharma is acquiring the patent estate, preclinical data and manufacturing research relating to Alexion’s ENPP1 gene deficiency program. The price was not disclosed.
In exchange for the assets, Alexion received an undisclosed number of shares of preferred stock representing a “single-digit” ownership stake in the company, Inozyme said.
ENPP1 deficiency is a rare, inherited, genetic inborn error of metabolism caused by mutations in the ENPP1 gene, according to Inozyme’s website. It can lead to life-threatening narrowing of the arteries in infants and cause rickets in children and adults.
The company has been developing a drug to correct a defect in the mineralization pathway caused by the deficiency.
Yale School of Medicine professors Joseph Schlessinger and Demetrios Braddock, MD, co-founded Inozyme in 2017 to commercialize technology developed in Braddock’s lab at Yale.
Rajinder Khunkhun, Alexion’s head of business development. said the agreement “represents an innovative opportunity to advance the development of therapies for ENPP1 gene deficiencies.”
Based in Boston, New Haven-born Alexion has a large research presence at 100 College St.
Contact Natalie Missakian at news@newhavenbiz.com
This special edition informs and connects businesses with nonprofit organizations that are aligned with what they care about. Each nonprofit profile provides a crisp snapshot of the organization’s mission, goals, area of service, giving and volunteer opportunities and board leadership.
Learn moreHartford Business Journal provides the top coverage of news, trends, data, politics and personalities of the area’s business community. Get the news and information you need from the award-winning writers at HBJ. Don’t miss out - subscribe today.
SubscribeDelivering Vital Marketplace Content and Context to Senior Decision Makers Throughout Greater Hartford and the State ... All Year Long!
Read HereThis special edition informs and connects businesses with nonprofit organizations that are aligned with what they care about. Each nonprofit profile provides a crisp snapshot of the organization’s mission, goals, area of service, giving and volunteer opportunities and board leadership.
Hartford Business Journal provides the top coverage of news, trends, data, politics and personalities of the area’s business community. Get the news and information you need from the award-winning writers at HBJ. Don’t miss out - subscribe today.
Delivering Vital Marketplace Content and Context to Senior Decision Makers Throughout Greater Hartford and the State ... All Year Long!
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
This website uses cookies to ensure you get the best experience on our website. Our privacy policy
To ensure the best experience on our website, articles cannot be read without allowing cookies. Please allow cookies to continue reading. Our privacy policy
0 Comments